| 37347242 | ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2023 |
| 37490054 | Management of individuals with germline pathogenic/likely pathogenic variants in CHEK2: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2023 |
| 37421176 | Most people share genetic test results with relatives even if the findings are normal: Family communication in a diverse population. | Genet Med | 2023 |
| 34302314 | Barriers to family history knowledge and family communication among LGBTQ+ individuals in the context of hereditary cancer risk assessment. | J Genet Couns | 2022 |
| 35802134 | ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2022 |
| 35707062 | Lessons learned and recommendations for data coordination in collaborative research: The CSER consortium experience. | HGG Adv | 2022 |
| 35834113 | Variation among DNA banking consent forms: points for clinicians to bank on. | J Community Genet | 2022 |
| 35522237 | ORCA, a values-based decision aid for selecting additional findings from genomic sequencing in adults: Efficacy results from a randomized trial. | Genet Med | 2022 |
| 36053287 | An accessible, relational, inclusive, and actionable (ARIA) model of genetic counseling compared with usual care: Results of a randomized controlled trial. | Genet Med | 2022 |
| 35123916 | Corrigendum to "Cancer Health Assessments Reaching Many (CHARM): A clinical trial assessing a multimodal cancer genetics services delivery program and its impact on diverse populations" [Contemporary Clinical Trials 106 (2021) 106432]. | Contemp Clin Trials | 2022 |
| 33278053 | A review and definition of 'usual care' in genetic counseling trials to standardize use in research. | J Genet Couns | 2021 |
| 33596141 | Patient-Reported Outcomes and Experiences with Population Genetic Testing Offered Through a Primary Care Network. | Genet Test Mol Biomarkers | 2021 |
| 33805616 | Genomic Sequencing Results Disclosure in Diverse and Medically Underserved Populations: Themes, Challenges, and Strategies from the CSER Consortium. | J Pers Med | 2021 |
| 33722076 | Scaling Genetic Counseling in the Genomics Era. | Annu Rev Genomics Hum Genet | 2021 |
| 33549385 | Development and early implementation of an Accessible, Relational, Inclusive and Actionable approach to genetic counseling: The ARIA model. | Patient Educ Couns | 2021 |
| 34345026 | Correction to: ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2021 |
| 34012069 | Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2021 |
| 34012068 | ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2021 |
| 33984519 | Cancer Health Assessments Reaching Many (CHARM): A clinical trial assessing a multimodal cancer genetics services delivery program and its impact on diverse populations. | Contemp Clin Trials | 2021 |
| 33407467 | ShareDNA: a smartphone app to facilitate family communication of genetic results. | BMC Med Genomics | 2021 |
| 33066060 | Primary Care Physician Experiences with Integrated Population-Scale Genetic Testing: A Mixed-Methods Assessment. | J Pers Med | 2020 |
| 33108757 | Variant Classification Concordance using the ACMG-AMP Variant Interpretation Guidelines across Nine Genomic Implementation Research Studies. | Am J Hum Genet | 2020 |
| 30670880 | Correction: Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study. | Genet Med | 2019 |
| 31317629 | Insurance coverage does not predict outcomes of genetic testing: The search for meaning in payer decisions for germline cancer tests. | J Genet Couns | 2019 |
| 31400517 | Clinical exome sequencing vs. usual care for hereditary colorectal cancer diagnosis: A pilot comparative effectiveness study. | Contemp Clin Trials | 2019 |
| 31422818 | Rates of Actionable Genetic Findings in Individuals with Colorectal Cancer or Polyps Ascertained from a Community Medical Setting. | Am J Hum Genet | 2019 |
| 30964586 | The Feelings About genomiC Testing Results (FACToR) Questionnaire: Development and Preliminary Validation. | J Genet Couns | 2019 |
| 30287922 | Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study. | Genet Med | 2019 |
| 28858330 | Navigating the research-clinical interface in genomic medicine: analysis from the CSER Consortium. | Genet Med | 2018 |
| 30193136 | The Clinical Sequencing Evidence-Generating Research Consortium: Integrating Genomic Sequencing in Diverse and Medically Underserved Populations. | Am J Hum Genet | 2018 |
| 30133189 | Approaches to carrier testing and results disclosure in translational genomics research: The clinical sequencing exploratory research consortium experience. | Mol Genet Genomic Med | 2018 |
| 30267214 | Rare loss of function variants in candidate genes and risk of colorectal cancer. | Hum Genet | 2018 |
| 30455898 | A case for expanding carrier testing to include actionable X-linked disorders. | Clin Case Rep | 2018 |
| 29754767 | Preconception Carrier Screening by Genome Sequencing: Results from the Clinical Laboratory. | Am J Hum Genet | 2018 |
| 29497922 | Why Patients Decline Genomic Sequencing Studies: Experiences from the CSER Consortium. | J Genet Couns | 2018 |
| 29739461 | Clinical providers' experiences with returning results from genomic sequencing: an interview study. | BMC Med Genomics | 2018 |
| 27490114 | Is "incidental finding" the best term?: a study of patients' preferences. | Genet Med | 2017 |
| 28361104 | Discordance in selected designee for return of genomic findings in the event of participant death and estate executor. | Mol Genet Genomic Med | 2017 |
| 28079899 | Genome sequencing and carrier testing: decisions on categorization and whether to disclose results of carrier testing. | Genet Med | 2017 |
| 27811861 | A survey of current practices for genomic sequencing test interpretation and reporting processes in US laboratories. | Genet Med | 2017 |
| 26889673 | Generating a taxonomy for genetic conditions relevant to reproductive planning. | Am J Med Genet A | 2016 |
| 26637299 | Next Generation Sequencing in the Clinic: a Patterns of Care Study in a Retrospective Cohort of Subjects Referred to a Genetic Medicine Clinic for Suspected Lynch Syndrome. | J Genet Couns | 2016 |
| 27392080 | Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine. | Am J Hum Genet | 2016 |
| 27392081 | Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium. | Am J Hum Genet | 2016 |
| 27422780 | Family Studies for Classification of Variants of Uncertain Classification: Current Laboratory Clinical Practice and a New Web-Based Educational Tool. | J Genet Couns | 2016 |
| 27181682 | Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine. | Am J Hum Genet | 2016 |
| 27181684 | Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium. | Am J Hum Genet | 2016 |
| 25741865 | Development of clinical decision support alerts for pharmacogenomic incidental findings from exome sequencing. | Genet Med | 2015 |
| 26537056 | ADCY5-related dyskinesia: Broader spectrum and genotype-phenotype correlations. | Neurology | 2015 |
| 26479557 | Patients' Choices for Return of Exome Sequencing Results to Relatives in the Event of Their Death. | J Law Med Ethics | 2015 |